ICU Medical, Incorporated (ICUI) Shares Bought by TD Asset Management Inc.

TD Asset Management Inc. increased its stake in ICU Medical, Incorporated (NASDAQ:ICUI) by 3.1% in the 1st quarter, HoldingsChannel reports. The fund owned 50,248 shares of the medical instruments supplier’s stock after purchasing an additional 1,500 shares during the quarter. TD Asset Management Inc.’s holdings in ICU Medical were worth $12,026,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Zurcher Kantonalbank Zurich Cantonalbank grew its position in ICU Medical by 6.5% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,118 shares of the medical instruments supplier’s stock valued at $268,000 after purchasing an additional 68 shares during the period. Oregon Public Employees Retirement Fund grew its position in ICU Medical by 1.4% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 6,646 shares of the medical instruments supplier’s stock valued at $1,591,000 after purchasing an additional 90 shares during the period. Huntington National Bank grew its position in ICU Medical by 26.6% in the 4th quarter. Huntington National Bank now owns 443 shares of the medical instruments supplier’s stock valued at $102,000 after purchasing an additional 93 shares during the period. Advisory Services Network LLC grew its position in ICU Medical by 475.0% in the 4th quarter. Advisory Services Network LLC now owns 115 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 95 shares during the period. Finally, New York State Teachers Retirement System grew its position in ICU Medical by 0.4% in the 4th quarter. New York State Teachers Retirement System now owns 24,739 shares of the medical instruments supplier’s stock valued at $5,681,000 after purchasing an additional 100 shares during the period. 90.05% of the stock is owned by institutional investors and hedge funds.

ICUI has been the subject of several research reports. BidaskClub raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, February 20th. Raymond James reduced their price target on shares of ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating for the company in a research report on Friday, March 1st. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $262.00 price target for the company in a research report on Thursday, March 7th. Finally, TheStreet downgraded shares of ICU Medical from a “b-” rating to a “c+” rating in a research report on Tuesday, March 19th. Three analysts have rated the stock with a hold rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $281.00.

In other ICU Medical news, VP Virginia Ruth Sanzone sold 5,277 shares of ICU Medical stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $232.31, for a total transaction of $1,225,899.87. Following the transaction, the vice president now directly owns 13,167 shares of the company’s stock, valued at approximately $3,058,825.77. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Christian B. Voigtlander sold 5,348 shares of ICU Medical stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $227.59, for a total value of $1,217,151.32. Following the sale, the chief operating officer now owns 4,732 shares in the company, valued at $1,076,955.88. The disclosure for this sale can be found here. Insiders have sold a total of 12,318 shares of company stock worth $2,839,576 over the last ninety days. Insiders own 11.40% of the company’s stock.

ICUI opened at $225.66 on Monday. The firm has a market cap of $4.65 billion, a price-to-earnings ratio of 29.27 and a beta of 0.69. ICU Medical, Incorporated has a 1 year low of $210.94 and a 1 year high of $321.70.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $2.35 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.96 by $0.39. The firm had revenue of $330.93 million for the quarter, compared to the consensus estimate of $318.97 million. ICU Medical had a net margin of 4.04% and a return on equity of 13.70%. The business’s revenue for the quarter was down 11.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.26 EPS. As a group, sell-side analysts anticipate that ICU Medical, Incorporated will post 8.55 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “ICU Medical, Incorporated (ICUI) Shares Bought by TD Asset Management Inc.” was originally reported by WKRB News and is the sole property of of WKRB News. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://www.wkrb13.com/2019/05/27/icu-medical-incorporated-icui-shares-bought-by-td-asset-management-inc.html.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: What is Depreciation?

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.